Nifty

:

23053.10

Sensex

:

74459.53

116.35 (0.51%)
308.49 (0.42%)

Login

Nifty
Sensex

:
:

23053.10
74459.53

116.35 (0.51%)
308.49 (0.42%)

Eiko Lifesciences Ltd.

Chemicals

Rating :

59/99

BSE: 540204 | NSE: Not Listed

Watchlist

NSE BSE

50.72

30-Oct-2026

Open
High
Low
Previous Close

52.64
52.93
50.27
51.52

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1609
81742
52.93
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

75.07
14.75
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

66.19
N/A
1.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

59.31
10.64
14.69

EBITDA CAGR (%)

10 Years
5 Years
3 Years

28.81
20.08
15.08

PAT CAGR (%)

10 Years
5 Years
3 Years

35.63
38.21
68.37

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.60
0.92
0.58

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-17.63
-18.71
-13.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 14.18 7.45 90.34% 15.90 7.09 124.26% 9.57 6.91 38.49% 9.20 7.74 18.86%
Expenses 13.27 6.93 91.49% 14.68 6.58 123.10% 8.70 6.46 34.67% 8.48 7.39 14.75%
EBITDA 0.91 0.52 75.00% 1.23 0.51 141.18% 0.87 0.45 93.33% 0.72 0.35 105.71%
EBIDTM 6.42% 6.98% 7.70% 7.25% 9.11% 6.55% 7.83% 4.50%
Other Income 0.68 0.55 23.64% 0.45 0.53 -15.09% 0.56 0.11 409.09% 0.57 0.13 338.46%
Interest 0.04 0.02 100.00% 0.04 0.04 0.00% 0.04 0.02 100.00% 0.07 0.04 75.00%
Depreciation 0.15 0.15 0.00% 0.15 0.15 0.00% 0.15 0.15 0.00% 0.15 0.16 -6.25%
PBT 1.41 0.91 54.95% 1.49 1.20 24.17% 1.24 0.38 226.32% 1.07 0.28 282.14%
Tax 0.34 0.22 54.55% 0.37 0.30 23.33% 0.30 0.10 200.00% 0.25 0.07 257.14%
PAT 1.06 0.69 53.62% 1.13 0.90 25.56% 0.95 0.28 239.29% 0.82 0.21 290.48%
PATM 7.51% 9.30% 7.07% 12.70% 9.89% 4.11% 8.88% 2.69%
EPS 0.72 0.47 53.19% 0.77 0.61 26.23% 0.64 0.19 236.84% 0.56 0.14 300.00%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 16.75 10.71 56.40% 18.34 11.27 62.73% 11.98 7.49 59.95% 11.67 8.15 43.19%
Expenses 14.81 9.20 60.98% 16.05 9.96 61.14% 10.11 6.85 47.59% 9.91 7.73 28.20%
EBITDA 1.94 1.51 28.48% 2.29 1.31 74.81% 1.88 0.63 198.41% 1.77 0.42 321.43%
EBIDTM 11.57% 14.12% 12.46% 11.65% 15.65% 8.47% 15.13% 5.15%
Other Income 0.41 0.27 51.85% 0.13 0.23 -43.48% 0.32 0.09 255.56% 0.26 0.13 100.00%
Interest 0.13 0.05 160.00% 0.12 0.07 71.43% 0.07 0.03 133.33% 0.10 0.04 150.00%
Depreciation 0.25 0.25 0.00% 0.25 0.25 0.00% 0.26 0.16 62.50% 0.26 0.16 62.50%
PBT 1.96 1.48 32.43% 2.05 1.57 30.57% 1.87 0.54 246.30% 1.67 0.35 377.14%
Tax 0.49 0.37 32.43% 0.52 0.39 33.33% 0.48 0.14 242.86% 0.43 0.09 377.78%
PAT 1.47 1.11 32.43% 1.53 1.18 29.66% 1.40 0.40 250.00% 1.24 0.26 376.92%
PATM 8.80% 10.33% 8.32% 10.43% 11.64% 5.30% 10.67% 3.16%
EPS 1.05 0.81 29.63% 0.91 0.76 19.74% 0.88 0.32 175.00% 0.78 0.22 254.55%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 48.85 42.13 32.49 27.93 18.32 25.41 11.99 0.00 0.36 0.49 0.40 Net Sales Growth 67.35% 29.67% 16.33% 52.46% -27.90% 111.93% 0 -100% -26.53% 22.50% Cost Of Goods Sold 43.56 37.29 29.21 25.41 16.09 22.58 10.62 0.00 0.00 0.00 0.00 Gross Profit 5.29 4.83 3.29 2.52 2.23 2.83 1.38 0.00 0.36 0.49 0.40 GP Margin 10.82% 11.46% 10.13% 9.02% 12.17% 11.14% 11.51% 0 100% 100% 100% Total Expenditure 45.13 38.86 30.78 26.31 17.36 24.10 11.47 0.17 0.19 0.18 0.14 Power & Fuel Cost - 0.22 0.19 0.07 0.04 0.10 0.02 0.00 0.00 0.00 0.00 % Of Sales - 0.52% 0.58% 0.25% 0.22% 0.39% 0.17% 0 0% 0% 0% Employee Cost - 0.23 0.22 0.16 0.23 0.23 0.12 0.07 0.02 0.07 0.06 % Of Sales - 0.55% 0.68% 0.57% 1.26% 0.91% 1.00% 0 5.56% 14.29% 15.00% Manufacturing Exp. - 0.52 0.74 0.14 0.50 0.74 0.45 0.00 0.00 0.00 0.00 % Of Sales - 1.23% 2.28% 0.50% 2.73% 2.91% 3.75% 0 0% 0% 0% General & Admin Exp. - 0.44 0.37 0.47 0.48 0.40 0.14 0.09 0.16 0.07 0.07 % Of Sales - 1.04% 1.14% 1.68% 2.62% 1.57% 1.17% 0 44.44% 14.29% 17.50% Selling & Distn. Exp. - 0.05 0.04 0.04 0.02 0.04 0.11 0.01 0.00 0.01 0.00 % Of Sales - 0.12% 0.12% 0.14% 0.11% 0.16% 0.92% 0 0% 2.04% 0% Miscellaneous Exp. - 0.11 0.01 0.01 0.00 0.02 0.01 0.00 0.01 0.03 0.00 % Of Sales - 0.26% 0.03% 0.04% 0% 0.08% 0.08% 0 2.78% 6.12% 2.50% EBITDA 3.73 3.27 1.71 1.62 0.96 1.31 0.52 -0.17 0.17 0.31 0.26 EBITDA Margin 7.64% 7.76% 5.26% 5.80% 5.24% 5.16% 4.34% 0 47.22% 63.27% 65.00% Other Income 2.26 2.23 1.02 0.18 0.85 0.67 0.46 0.43 0.02 0.02 0.00 Interest 0.19 0.19 0.13 0.15 0.16 0.48 0.09 0.07 0.03 0.05 0.02 Depreciation 0.60 0.59 0.63 0.66 0.63 0.56 0.06 0.06 0.06 0.06 0.02 PBT 5.21 4.71 1.98 0.98 1.03 0.94 0.83 0.13 0.10 0.22 0.22 Tax 1.26 1.13 0.58 0.23 0.26 0.24 0.22 0.00 0.03 0.04 0.05 Tax Rate 24.18% 23.99% 25.00% 23.47% 25.24% 25.53% 26.51% 0.00% 30.00% 18.18% 22.73% PAT 3.96 3.58 1.74 0.75 0.77 0.71 0.61 0.13 0.07 0.18 0.17 PAT before Minority Interest 3.96 3.58 1.74 0.75 0.77 0.71 0.61 0.13 0.07 0.18 0.17 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.11% 8.50% 5.36% 2.69% 4.20% 2.79% 5.09% 0 19.44% 36.73% 42.50% PAT Growth 90.38% 105.75% 132.00% -2.60% 8.45% 16.39% 369.23% 85.71% -61.11% 5.88% EPS 2.69 2.44 1.18 0.51 0.52 0.48 0.41 0.09 0.05 0.12 0.12

Description TTM Mar 26 Mar 25 Mar 20 Mar 19 Mar 18
Net Sales 58.74 52.57 37.66 10.40 4.25 2.34 Net Sales Growth 56.14% 39.59% 262.12% 144.71% 81.62% Cost Of Goods Sold 46.52 41.29 32.66 7.61 3.07 1.37 Gross Profit 12.22 11.28 5.00 2.79 1.17 0.96 GP Margin 20.81% 21.46% 13.28% 26.83% 27.53% 41.03% Total Expenditure 50.88 45.34 34.90 14.91 4.95 2.02 Power & Fuel Cost - 0.22 0.19 0.00 0.00 0.00 % Of Sales - 0.42% 0.50% 0% 0% 0% Employee Cost - 0.48 0.29 2.58 0.78 0.18 % Of Sales - 0.91% 0.77% 24.81% 18.35% 7.69% Manufacturing Exp. - 0.52 0.74 2.04 0.49 0.12 % Of Sales - 0.99% 1.96% 19.62% 11.53% 5.13% General & Admin Exp. - 2.11 0.94 0.66 0.43 0.16 % Of Sales - 4.01% 2.50% 6.35% 10.12% 6.84% Selling & Distn. Exp. - 0.59 0.05 1.56 0.15 0.11 % Of Sales - 1.12% 0.13% 15.00% 3.53% 4.70% Miscellaneous Exp. - 0.13 0.03 0.46 0.02 0.08 % Of Sales - 0.25% 0.08% 4.42% 0.47% 3.42% EBITDA 7.88 7.23 2.76 -4.51 -0.70 0.32 EBITDA Margin 13.42% 13.75% 7.33% -43.37% -16.47% 13.68% Other Income 1.12 1.21 0.72 0.01 0.06 0.09 Interest 0.42 0.36 0.17 0.24 0.19 0.09 Depreciation 1.02 1.02 0.74 0.19 0.17 0.08 PBT 7.55 7.06 2.58 -4.93 -1.00 0.25 Tax 1.92 1.79 0.75 -1.31 -0.21 0.05 Tax Rate 25.43% 25.35% 25.68% 26.57% 21.00% 20.00% PAT 5.64 4.49 2.11 -1.91 -0.44 0.20 PAT before Minority Interest 5.01 5.32 2.32 -3.62 -0.78 0.20 Minority Interest -0.63 -0.83 -0.21 1.71 0.34 0.00 PAT Margin 9.60% 8.54% 5.60% -18.37% -10.35% 8.55% PAT Growth 91.19% 112.80% - - - EPS 3.84 3.05 1.44 -1.30 -0.30 0.14

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 67.50 56.42 50.68 29.42 28.63 12.53 5.48 5.43 5.55 3.23 Share Capital 14.35 13.76 12.87 8.32 8.32 3.82 3.82 3.82 3.82 3.02 Total Reserves 49.10 42.66 37.81 21.11 20.31 2.37 1.66 1.61 1.73 0.21 Non-Current Liabilities 0.76 1.68 0.56 0.42 0.26 0.10 0.14 0.25 0.37 0.38 Secured Loans 0.00 1.00 0.00 0.00 0.05 0.13 0.20 0.26 0.31 0.37 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 14.53 2.27 1.50 1.20 6.01 3.96 0.08 0.08 0.06 0.15 Trade Payables 12.43 1.11 1.38 1.05 1.35 1.90 0.00 0.00 0.00 0.00 Other Current Liabilities 0.02 0.17 0.04 0.11 0.12 0.09 0.06 0.07 0.05 0.05 Short Term Borrowings 1.67 0.76 0.00 0.00 4.50 1.63 0.00 0.00 0.00 0.00 Short Term Provisions 0.41 0.24 0.08 0.05 0.03 0.35 0.02 0.01 0.01 0.09 Total Liabilities 82.79 60.37 52.74 31.04 34.90 16.59 5.70 5.76 5.98 3.76 Net Block 13.67 14.26 13.57 13.88 14.29 0.25 0.31 0.37 0.43 0.49 Gross Block 16.99 16.99 15.69 15.34 15.12 0.52 0.52 0.52 0.52 0.52 Accumulated Depreciation 3.32 2.73 2.13 1.46 0.83 0.27 0.21 0.14 0.08 0.02 Non Current Assets 44.34 31.82 21.81 21.74 22.46 5.89 5.61 5.05 4.91 3.45 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 15.15 7.07 4.02 0.05 0.20 0.22 0.50 2.13 3.58 2.45 Long Term Loans & Adv. 15.51 10.49 4.23 6.68 2.30 3.61 3.35 1.18 0.82 0.00 Other Non Current Assets 0.00 0.00 0.00 1.12 5.67 1.81 1.45 1.37 0.08 0.51 Current Assets 38.45 28.56 30.93 9.30 12.44 10.70 0.10 0.71 1.07 0.30 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 3.97 4.02 3.39 0.91 5.46 0.06 0.00 0.00 0.00 0.00 Sundry Debtors 18.89 10.14 13.13 7.11 4.56 3.41 0.00 0.08 0.00 0.00 Cash & Bank 13.55 11.51 13.35 0.61 0.22 4.07 0.02 0.03 0.73 0.01 Other Current Assets 2.04 0.14 0.01 0.06 2.20 3.16 0.09 0.59 0.33 0.29 Short Term Loans & Adv. 0.68 2.75 1.05 0.62 2.18 2.76 0.01 0.29 0.29 0.29 Net Current Assets 23.92 26.29 29.42 8.10 6.43 6.74 0.02 0.63 1.01 0.16 Total Assets 82.79 60.38 52.74 31.04 34.90 16.59 5.71 5.76 5.98 3.75

Description Mar 26 Mar 25 Mar 20 Mar 19 Mar 18
Shareholder's Funds 68.78 56.79 2.95 4.92 5.56 Share Capital 14.35 13.76 3.82 3.82 3.82 Total Reserves 50.38 43.03 -0.87 1.10 1.74 Non-Current Liabilities 4.17 2.83 -0.02 0.15 0.51 Secured Loans 3.06 2.01 1.61 0.42 0.48 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 Current Liabilities 15.38 6.27 9.33 4.08 4.66 Trade Payables 12.56 3.31 3.85 1.40 2.29 Other Current Liabilities 0.55 1.79 5.45 1.68 1.05 Short Term Borrowings 1.67 0.76 0.00 0.94 1.27 Short Term Provisions 0.60 0.40 0.04 0.05 0.06 Total Liabilities 89.38 66.11 10.43 9.03 10.95 Net Block 22.10 23.12 1.75 1.71 1.68 Gross Block 25.95 25.95 2.68 2.45 2.27 Accumulated Depreciation 3.85 2.84 0.93 0.74 0.58 Non Current Assets 41.96 33.22 5.39 4.86 4.98 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 Non Current Investment 15.29 7.15 0.10 1.72 3.17 Long Term Loans & Adv. 4.57 2.95 2.09 0.05 0.04 Other Non Current Assets 0.00 0.00 1.45 1.37 0.08 Current Assets 47.41 32.88 5.03 4.17 5.98 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 3.97 5.77 3.21 2.31 3.10 Sundry Debtors 20.22 10.79 1.18 0.86 1.46 Cash & Bank 13.61 11.78 0.02 0.11 0.80 Other Current Assets 9.61 0.00 0.14 0.31 0.61 Short Term Loans & Adv. 9.55 4.53 0.47 0.58 0.57 Net Current Assets 32.03 26.61 -4.30 0.09 1.32 Total Assets 89.37 66.10 10.42 9.03 10.96

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 6.92 2.05 -7.08 4.22 -7.73 -0.83 0.77 -0.19 0.24 0.19 PBT 4.71 2.32 0.98 1.03 0.94 0.83 0.13 0.10 0.22 0.22 Adjustment -1.15 -0.51 0.62 0.02 0.38 -0.21 0.06 0.07 0.11 0.04 Changes in Working Capital 4.34 0.53 -8.65 3.10 -8.84 -1.27 0.60 -0.33 -0.05 -0.01 Cash after chg. in Working capital 7.90 2.34 -7.05 4.15 -7.52 -0.64 0.78 -0.16 0.28 0.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.98 -0.29 -0.03 0.08 -0.21 -0.18 -0.01 -0.03 -0.04 -0.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -11.21 -9.85 -0.55 0.87 0.59 -2.94 -0.65 -0.43 -1.33 -0.38 Net Fixed Assets 0.00 -1.30 -0.35 -0.22 -14.60 0.00 0.00 0.00 0.00 -0.52 Net Investments -8.08 -3.05 -3.97 0.15 0.02 0.28 1.63 1.45 -1.13 0.14 Others -3.13 -5.50 3.77 0.94 15.17 -3.22 -2.28 -1.88 -0.20 0.00 Cash from Financing Activity 6.33 5.97 20.36 -4.70 3.28 7.81 -0.13 -0.08 1.82 0.15 Net Cash Inflow / Outflow 2.04 -1.83 12.73 0.40 -3.85 4.05 -0.01 -0.71 0.72 -0.04 Opening Cash & Equivalents 11.51 13.35 0.61 0.22 4.07 0.02 0.03 0.73 0.01 0.05 Closing Cash & Equivalent 13.55 11.51 13.35 0.61 0.22 4.07 0.02 0.03 0.73 0.01

Description Mar 26 Mar 25 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 2.25 2.78 -0.33 0.16 0.00 PBT 7.12 3.06 -4.93 -1.00 0.00 Adjustment 0.22 -0.30 0.36 0.34 0.00 Changes in Working Capital -3.68 0.32 4.27 0.84 0.00 Cash after chg. in Working capital 3.66 3.09 -0.30 0.19 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.41 -0.31 -0.02 -0.02 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -8.63 -11.30 -0.71 -0.30 0.00 Net Fixed Assets 0.00 -16.47 0.00 0.00 Net Investments -8.08 -6.57 1.63 1.45 Others -0.55 11.74 -2.34 -1.75 Cash from Financing Activity 8.21 6.96 0.95 -0.55 0.00 Net Cash Inflow / Outflow 1.83 -1.57 -0.09 -0.69 0.00 Opening Cash & Equivalents 11.78 13.35 0.11 0.80 0.00 Closing Cash & Equivalent 13.61 11.78 0.02 0.11 0.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 44.22 41.00 39.37 30.66 29.83 16.19 14.35 14.21 14.52 10.69 ROA 5.00% 3.08% 1.79% 2.33% 2.74% 5.51% 2.23% 1.23% 3.75% 4.75% ROE 5.98% 3.25% 1.88% 2.65% 4.05% 10.53% 2.34% 1.32% 4.16% 5.35% ROCE 7.70% 4.50% 2.82% 3.77% 5.96% 9.18% 3.46% 2.25% 5.60% 6.83% Fixed Asset Turnover 2.48 1.99 1.80 1.20 3.25 23.28 0.00 0.71 0.96 0.77 Receivable days 125.75 130.70 132.25 116.23 57.29 103.95 0.00 84.79 0.00 0.00 Inventory Days 34.61 41.58 28.05 63.40 39.65 1.93 0.00 0.00 0.00 0.00 Payable days 66.25 15.55 17.42 27.15 26.21 32.59 0.00 0.00 0.57 0.00 Cash Conversion Cycle 94.11 156.73 142.89 152.48 70.73 73.28 0.00 84.79 -0.57 0.00 Total Debt/Equity 0.03 0.03 0.00 0.00 0.16 0.30 0.05 0.06 0.07 0.13 Interest Cover 25.84 18.36 7.76 7.57 2.98 10.35 2.90 4.11 5.83 15.45

Description Mar 26 Mar 25 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 45.12 41.26 7.71 12.89 14.56 ROA 6.85% 6.06% -37.22% -7.85% 1.83% ROE 8.76% 7.76% -92.01% -14.96% 3.61% ROCE 11.23% 10.08% -86.53% -11.96% 4.56% Fixed Asset Turnover 2.03 2.63 4.05 1.80 1.03 Receivable days 107.63 57.98 35.79 99.91 228.50 Inventory Days 33.84 43.54 96.92 232.74 484.30 Payable days 70.15 40.04 70.22 168.32 494.04 Cash Conversion Cycle 71.31 61.48 62.50 164.33 218.75 Total Debt/Equity 0.07 0.05 0.55 0.28 0.31 Interest Cover 20.97 19.55 -19.34 -4.39 3.82

Top Investors:

2b black bio llp .

ashika global finance pvt. ltd.

ashok vishwanath hiremath

sushila paraskumar daga

sivanesan sellappan

joyanta kumar jana

parshva kumar daga

bhavinkumar vinaychand shah

v square pharmachem private limited

Annual Reports:

News Update:

Eiko Lifesciences - Quarterly Results
13th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback